Peter D. Staple

Former President & Chief Executive Officer at Corium International, Inc.

Peter D. Staple

Peter D. Staple

Former President & Chief Executive Officer at Corium International, Inc.

Overview
Career Highlights

ALZA Corp.
Chiron Corp.
Corium International, Inc.

RelSci Relationships

479

Number of Boards

3

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals Peter D. Staple likely has professional access to. A relationship does not necessarily indicate a personal connection.

Senior Associate Dean for Education at Stanford University

Relationship likelihood: Strong

Professional at Corium International, Inc.

Relationship likelihood: Strong

Managing Director at Essex Woodlands Management, Inc.

Relationship likelihood: Strong

Former Executive Chairman at Corium International, Inc.

Relationship likelihood: Strong

Chief Executive Officer at EIS, Inc.

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Aimmune Therapeutics, Inc.

Relationship likelihood: Strong

Operating Partner at Frazier Management LLC

Relationship likelihood: Strong

Co-Founder & Chief Executive Officer at OncoNano Medicine, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Corium International, Inc.

Relationship likelihood: Strong

Professional at Corium International, Inc.

Relationship likelihood: Strong

Paths to Peter D. Staple
Potential Connections via
Relationship Science
You
Peter D. Staple
Former President & Chief Executive Officer at Corium International, Inc.
Education
B.A Degree

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

J.D. Degree

Stanford began offering a curriculum in legal studies in 1893, when the university engaged its first two law professors. One was Benjamin Harrison, former President of the United States, who delivered a landmark series of lectures on the Constitution. The other was Nathan Abbott, who served as head of the nascent law program. Abbott assembled a small faculty to which he imparted a standard of rigor and excellence that endures to this day.In an effort to acknowledge the emerging professional nature of the department, Stanford's Board of Trustees passed a resolution in 1908 to substitute the term 'law school' for 'law department,' though technically the law program remained a department within the university.The law school was at the forefront of efforts to institute the California Bar exam, which was added to the requirements to practice law in California in 1919. The law school was accredited by the American Bar Association in 1923, the year the ABA began certifying law schools.

Career History
President & Chief Executive Officer
2008 - 2019

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Chief Executive Officer
2002 - 2008

BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development.Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand.Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.

Chief Administrative Officer & General Counsel
1994 - 2002

ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA.

Boards & Committees
Director
2002 - 2008

BioSeek, an Asterand company, is improving the success rate of pharmaceutical research and development by integrating human biology from the earliest stages of drug discovery onward. Their BioMAP® Systems incorporate predictive primary human cell-based disease models that generate uniquely informative biological activity profiles for each potential drug. As a result, their technology drives the selection and development of new drug candidates. they leverage their BioMAP® Systems technology in collaborations to enhance the productivity of their pharmaceutical partners' pipelines to identify promising compounds for therapeutic development.Asterand plc acquired BioSeek on February 18, 2010. Asterand is the leading global supplier of high quality, well characterized human tissue and human tissue-based research services to drug discovery scientists. BioSeek's BioMAP® platform and primary human cell based assays are highly complementary to the human tissue-based products and services offered by Asterand.Formed in January 2006 from the merger of Asterand, a human tissue biorepository, and Pharmagene, a human tissue-based drug discovery company, Asterand plc is uniquely positioned to provide a comprehensive approach to meet the research needs of pharmaceutical and biotechnology companies. From their offices in Royston (United Kingdom), San Francisco, California and Detroit, Michigan they have more than 90 employees focused on providing services and products to accelerate drug discovery research from target identification through to compound evaluation and drug safety.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$100 +
2005

TO UNLOCK THE POTENTIAL OF AT RISK CHILDREN AND FAMILIES AND CREATE OPPORTUNITIES FOR SUCCESS

$250 - $499
2003

TO UNLOCK THE POTENTIAL OF AT RISK CHILDREN AND FAMILIES AND CREATE OPPORTUNITIES FOR SUCCESS

Political Donations
$250
2000

Representative at Office of the Representative from California's 18th District, Anna Eshoo

$250
2000

Representative at Office of the Representative from California's 19th District, Zoe Lofgren

$250
2000

Partner at California Strategies LLC

Investments
Details Hidden

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Peter D. Staple. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Peter D. Staple's profile does not indicate a business or promotional relationship of any kind between RelSci and Peter D. Staple.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/peter-d-staple-3227492
  • https://relationshipscience.com/person/peter-d-staple-3227492